The idea of testing stem cells for COVID-19 may be music to the ears of some folks as an opportunity, but to me from the beginning it sounded mostly like a spaghetti on the wall road to trouble. There is buzz out there that some kind of stem cells or other cells will help with […]
Field throws stem cells for COVID-19 like spaghetti on the wall Read More »
There is always plenty of complicated, mixed-bag news on the stem cell and regenerative medicine front so it’s great to highlight when there’s some good news out there. Today’s post includes several such upbeat items. At the bottom I’ve included a list of some recent interesting publications as well. Good news on vision front: jCyte
Stem cell & regenerative medicine good news & pubs Read More »
It’s been a busy week for the cellular and regenerative medicine space for COVID-19 news with some possible ups including for Mesoblast and some definite downs. Starting with the more positive media buzz with have Mesoblast. Mesoblast made COVID19 news “Thinly traded Mesoblast Limited (NASDAQ:MESO) rockets 51% premarket on average volume in reaction to its announcement of an
COVID-19 cellular medicine buzz: Mesoblast, FTC hammer, more Read More »
Rudy Giuliani has been tweeting all kinds of wild things about the novel coronavirus and is apparently very excited about the idea of “stem cells” for COVID-19 patients. What could go wrong, right? Giuliani starts vaguely tweeting about “stem cells” I wrote a few days ago about how Giuliani had been plugging an upcoming podcast
Deconstructing Rudy Giuliani ‘stem cells for COVID-19’ podcast & NK cell transplant idea Read More »
Despite the COVID-19 pandemic there are still some research things we can do including data analysis as well as reading new papers and media articles on science, including regenerative medicine. If the weather’s good and you have wi-fi (or you print articles still on paper) you can even do this out in the fresh air
Recommended regenerative medicine reads plus COVID-19 stem cell hype Read More »
Could two stem cell biotechs Athersys and Mesoblast help in the battle against the novel coronavirus disease COVID-19? Stem cells, ARDS, and COVID-19 I’ve already written two pieces about the idea of using stem cells to battle COVID-19 (here and here), the sometimes fatal disease that arises from infection with the novel coronavirus. Older patients
Athersys & Mesoblast stem cells for COVID-19? Read More »
There’s never enough time to get all of one’s science reading done, but we can try! It helps to have a list of “to-read” articles, whether actual research articles or media pieces. In the old days, I remember my mentors saying they literally had “piles” of journal articles on their coffee tables, bathrooms, bedrooms, etc.
Weekly recommended science reads: stem cells, CRISPR, cancer & more Read More »
What’s on your weekend reads list including stem cell papers? In addition to hard-core research papers, I find some bigger picture publications to be helpful too. Then there are just fun items. Every so often I do a post about things that I’m hoping to find time to read over the weekend or that I’ve
Recommended recent stem cell, cancer, & CRISPR reads Read More »
Last year around this time I took my annual plunge to make 20 predictions for the coming year for the stem cell and regenerative medicine field. I even made a crystal ball graphic to highlight the complexity of the stem cell ecosystem into which these predictions were embedded (see image) for 2019. How’d I do?
B+ on my report card on my 20 stem cell predictions for 2019 Read More »
Stem cell treatment cost is a big issue for patients now and longer term also for the stem cell field. If proven stem cell treatments end up costing too much then all that hard work to invent and test the therapies won’t have helped people much. Million or multi-million dollar new therapies are not so
Stem cell treatment cost 2019: polls & more Read More »